Pregnant and breastfeeding women, individuals with active cancer or a history of specific oncological conditions, and those with severe kidney or liver disease should generally avoid taking NAD+ supplements unless specifically cleared by an oncologist or primary physician. Because NAD+ is crucial for cellular metabolism and growth, laboratory studies suggest that excessive boosting could theoretically influence cell proliferation, meaning vulnerable patient groups must prioritize medical guidance over general wellness trends.